PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2003
PHARMANIAGA BERHAD |
Quarterly report for the financial period ended | 31/12/2003 |
Quarter | 4 |
Financial Year End | 31/12/2003 |
The figures | have been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2003 | 31/12/2002 | 31/12/2003 | 31/12/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 166,617 | 129,787 | 632,604 | 585,237 |
2 | Profit/(loss) before tax | 18,664 | 11,287 | 66,841 | 61,170 |
3 | Profit/(loss) after tax and minority interest | 9,495 | 6,779 | 40,756 | 37,341 |
4 | Net profit/(loss) for the period | 9,495 | 6,779 | 40,756 | 37,341 |
5 | Basic earnings/(loss) per share (sen) | 9.47 | 6.78 | 40.70 | 37.34 |
6 | Dividend per share (sen) | 12.00 | 6.00 | 12.00 | 8.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 2.2200 | 1.8000 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
The Board of Directors of Pharmaniaga Berhad recommends a final tax exempt dividend of 8.5 sen per share. The dates of entitlement and payment will be announced at a later date. |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 19 Feb 2004 |
Category | Financial Results |
Reference No | CC-040217-40807 |